75A50123F61003↗
Advanced Technology International received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $723.52M obligated so far for health r&d services; health care - other; applied research. It runs to 2030-12-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Advanced Technology International
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Obligated to date
- $723.52M
- Potential value
- $723.52M
- Ends
- 2030-12-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75A50123F61003, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75A50123F61003_7505_75A50123D00005_7505
Advanced Technology International: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
OT TASK ORDER 3
What it is
- Product or service
- Health R&D Services; Health Care - Other; Applied Research (PSC AN42)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- Barda - Aspr / Daappo / Barda Dcma (75A501)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75A50123D00005
- Where the work is
- Berkeley, SC · district SC-01
- Funding law
- COVID-19 laws
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
7 actions since 2023-09-28. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-11 | P00006 | Administrative change | $0 | EOI:EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI DEOBLIGATION OF FUNDS AND PARTIAL DE-SCOPE |
| 2025-04-24 | P00005 | Funding only | -$200.00M | RRPV OTA TO3 "NEXTGEN THERAPEUTICS" |
| 2025-03-18 | P00004 | Administrative change | $0 | RRPV OTA TO3 "NEXTGEN THERAPEUTICS FOR COVID-19" |
| 2024-11-06 | P00003 | Administrative change | $0 | RRPV OTA TO3 "NEXTGEN THERAPEUTICS FOR COVID-19" |
| 2024-08-07 | P00002 | Supplemental agreement (work within scope) | $0 | OT TASK ORDER 3 "NEXTGEN THERAPEUTICS FOR COVID-19" |
| 2024-01-04 | P00001 | Supplemental agreement (work within scope) | $523.52M | OT TASK ORDER 3 |
| 2023-09-28 | 0 | $400.00M | OT TASK ORDER 3 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗